Surveying insulin prices, availability and affordability in Peru

An important problem related to access to diabetes treatment is limited availability of medicines. Previous research in Peru showed that approximately 30% of the population with diabetes were prescribed insulin in outpatient care. However, a study in Lima identified the insufficient availability of insulin and syringes in primary health care centers; insulin is provided only in public hospitals and private pharmacies, with prices three times higher than in PHC centers. There is not enough information about the situation in areas outside the capital in order to determine the magnitude of the problem.

Objective

To generate information on the price, availability and affordability of insulin in 6 areas of Peru.

Design:

This is a cross-sectional study. We will apply a survey adapted from the World Health Organization / Health Action International (OMS/HAI)’s methodology to collect information about price and availability of insulin, metformin, and syringes in pharmacies. We will survey 30 pharmacies from the Ministry of Health, as well as 30 private pharmacies, for a total of 60 pharmacies.

Results

Ongoing project.

Contact

María Lazo-Porras, MD,MSc
maria.lazo@upch.pe

Location

Lima, Junín, Arequipa, Ayacucho, La Libertad and San Martín.

Funding

Non-profit organization Health Action International.

Duration

2018

Research team

J. David Beran, Genève University.
Margaret Ewen, Health Action International.
María Lazo-Porras, CRONICAS, Universidad Peruana Cayetano Heredia.
Jaime Miranda, CRONICAS, Universidad Peruana Cayetano Heredia.

Contributors: Liliana Hidalgo, Janeth Tenorio.

Publications

News

Videos

Gallery